Primary Site >> Colorectal Cancer
Gene >> TACSTD2
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers. PMID: 11768609 |
Ref: Clinical significance of TROP2 expression in colorectal cancer. PMID: 16707602 |
Ref: Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. PMID: 17982676 |
Ref: TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. PMID: 18084248 |
Ref: Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. PMID: 19421758 Ref: [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance]. PMID: 19434540 |
Ref: (-)-Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. PMID: 20682974 |
Ref: A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. PMID: 20473941 Ref: Is there any association between TACSTD2, KIAA1253, Ku70 and mutant KRAS gene expression and clinical-pathological features of colorectal cancer? PMID: 21423092 |
Ref: Different effects of ERbeta and TROP2 expression in Chinese patients with early-stage colon cancer. PMID: 23055188 |
Ref: Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer. PMID: 26059528 Ref: Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line. PMID: 26133168 Ref: Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study. PMID: 26494939 |
Ref: Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library. PMID: 29719626 Ref: Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells. PMID: 30048976 |